cats receiving propylthiouracil ( ptu ) develop antinuclear antibodies ( ana ) and an immune-mediated disease syndrome characterized by anorexia , lymphadenopathy , weight loss , and coombs-positive hemolytic anemia .
C0021053
immune
C0497156
lymphadenopathy